Marshall Islands vs Mus: HIV-positive TB patients on ART (antiretroviral therapy)
Marshall Islands
100.0%
in 2019
Mus
100.0%
in 2024
Marshall Islands rank
1st
Mus rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Marshall Islands
- Mus
How they compare
Marshall Islands currently reports 100.0% against 100.0% in Mus, a difference of 0.0%.
The two have swapped places 1 time across 5 shared years of data; in 2009 it was Marshall Islands ahead.
Marshall Islands ranks 1st and Mus ranks 1st of 144 countries.
Marshall Islands has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Marshall Islands | Mus | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 71.0% | 29.0% | Marshall Islands |
| 2010s | 100.0% | 90.5% | 9.5% | Marshall Islands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Marshall Islands or Mus?
- Marshall Islands, at 100.0% against 100.0% in Mus as of 2019.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Marshall Islands and Mus?
- 0.0%, with Marshall Islands ahead.
- How many years of comparable data are there for Marshall Islands and Mus?
- 5 years are reported by both, from 2009 to 2019.
- How do Marshall Islands and Mus rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Marshall Islands ranks 1st and Mus ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.